Eyebright Medical Technology (Beijing) Co., Ltd. (SHA: 688050)

Eyebright Medical Technology (Beijing) Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Jun 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	608.4	536.66	354.9	472.87	536.84	196.33
Short-Term Investments	-	-	-	480	450	-
Trading Asset Securities	14.42	20.12	481.97	0.48	0.28	-
Cash & Short-Term Investments	622.82	556.78	836.86	953.35	987.12	196.33
Cash Growth	-15.62%	-33.47%	-12.22%	-3.42%	402.79%	-27.43%
Accounts Receivable	351.62	212.82	103.52	67.8	74.22	58.3
Other Receivables	7.67	6.03	3.71	6.57	4.69	1
Receivables	359.29	218.85	107.23	74.37	78.91	59.3
Inventory	214.38	181.35	78.83	56.02	59.07	60.78
Prepaid Expenses	-	-	-	0.15	1	0.61
Other Current Assets	64.26	65.89	38.36	34.83	20.08	17.5
Total Current Assets	1,261	1,023	1,061	1,119	1,146	334.52
Property, Plant & Equipment	1,393	1,257	674.21	558.69	267.13	183.13
Long-Term Investments	159.74	157.44	153.56	102.16	40.78	15.94
Goodwill	132.6	132.6	21.13	21.13	-	-
Other Intangible Assets	181.47	174.21	107.04	91.39	90.92	88.58
Long-Term Deferred Tax Assets	50.24	46.74	29.91	34.35	25.12	25.3
Long-Term Deferred Charges	135.39	105.72	60.83	67.49	49.57	19.23
Other Long-Term Assets	97.99	149.43	120.81	45.49	18.83	19.1
Total Assets	3,428	3,062	2,244	2,048	1,639	685.78
Accounts Payable	53.78	49.05	13.86	5.57	2.18	0.28
Accrued Expenses	53.14	50.87	42.59	31.82	17.97	12.75
Short-Term Debt	7.75	25.55	-	-	-	-
Current Portion of Long-Term Debt	142.07	92.39	-	-	-	-
Current Income Taxes Payable	3.76	2.31	13.5	6.99	4.1	2.3
Current Unearned Revenue	10.69	12.6	6.47	6.16	3.41	-
Other Current Liabilities	50.83	145	71.29	88.88	49.43	7.79
Total Current Liabilities	322.02	377.77	147.71	139.42	77.09	23.13
Long-Term Debt	583.88	287.44	149.77	143.37	-	-
Long-Term Leases	14.16	13.85	13.02	11.48	-	-
Long-Term Unearned Revenue	9.56	10.53	8.9	10.76	12.62	14.62
Long-Term Deferred Tax Liabilities	15.61	15.14	4.26	0.8	-	-
Other Long-Term Liabilities	1.3	1.13	0.64	1.63	1.18	0.51
Total Liabilities	946.53	705.85	324.3	307.46	90.89	38.26
Common Stock	189.54	105.25	105.18	105.14	105.14	78.85
Additional Paid-In Capital	1,228	1,325	1,311	1,318	1,305	527.53
Retained Earnings	856.34	699.81	444.01	250.23	107.74	11.18
Total Common Equity	2,255	2,130	1,860	1,674	1,518	617.56
Minority Interest	225.94	226.3	59.96	66.29	29.53	29.97
Shareholders' Equity	2,481	2,356	1,920	1,740	1,548	647.52
Total Liabilities & Equity	3,428	3,062	2,244	2,048	1,639	685.78
Total Debt	747.85	419.23	162.79	154.85	-	-
Net Cash (Debt)	-125.04	137.55	674.07	798.5	987.12	196.33
Net Cash Growth	-	-79.59%	-15.58%	-19.11%	402.79%	-25.04%
Net Cash Per Share	-0.66	0.72	3.56	4.22	6.13	1.39
Filing Date Shares Outstanding	189.54	189.45	189.32	189.25	189.25	141.93
Total Common Shares Outstanding	189.54	189.45	189.32	189.25	189.25	141.93
Working Capital	938.72	645.1	913.59	979.3	1,069	311.39
Book Value Per Share	11.90	11.24	9.83	8.84	8.02	4.35
Tangible Book Value	1,941	1,823	1,732	1,561	1,427	528.98
Tangible Book Value Per Share	10.24	9.62	9.15	8.25	7.54	3.73
Buildings	838.84	676.61	414.46	150.37	136.27	129.27
Machinery	773.46	618.13	232.76	155.95	102.28	85.88
Construction In Progress	17.68	154.26	120.6	318.44	81	3.62

Source: S&P Capital IQ. Standard template. Financial Sources.